ICD-10-CM Code A36

Diphtheria

Version 2020 Non-Billable Code

Not Valid for Submission

A36 is a "header" nonspecific and non-billable code code, consider using a code with a higher level of specificity for a diagnosis of diphtheria. The code is NOT valid for the year 2020 for the submission of HIPAA-covered transactions.

ICD-10:A36
Short Description:Diphtheria
Long Description:Diphtheria

Consider the following ICD-10 codes with a higher level of specificity:

  • A36.0 - Pharyngeal diphtheria
  • A36.1 - Nasopharyngeal diphtheria
  • A36.2 - Laryngeal diphtheria
  • A36.3 - Cutaneous diphtheria
  • A36.8 - Other diphtheria
  • A36.81 - Diphtheritic cardiomyopathy
  • A36.82 - Diphtheritic radiculomyelitis
  • A36.83 - Diphtheritic polyneuritis
  • A36.84 - Diphtheritic tubulo-interstitial nephropathy
  • A36.85 - Diphtheritic cystitis
  • A36.86 - Diphtheritic conjunctivitis
  • A36.89 - Other diphtheritic complications
  • A36.9 - ... unspecified

Clinical Information

  • DIPHTHERIA-. a localized infection of mucous membranes or skin caused by toxigenic strains of corynebacterium diphtheriae. it is characterized by the presence of a pseudomembrane at the site of infection. diphtheria toxin produced by c. diphtheriae can cause myocarditis polyneuritis and other systemic toxic effects.
  • DIPHTHERIA ANTITOXIN-. an antitoxin produced against the toxin of corynebacterium diphtheriae that is used for the treatment of diphtheria.
  • DIPHTHERIA TOXIN-. an adp ribosylating polypeptide produced by corynebacterium diphtheriae that causes the signs and symptoms of diphtheria. it can be broken into two unequal domains: the smaller catalytic a domain is the lethal moiety and contains monoadp ribose transferases which transfers adp ribose to peptide elongation factor 2 thereby inhibiting protein synthesis; and the larger b domain that is needed for entry into cells.
  • DIPHTHERIA TOXOID-. the formaldehyde inactivated toxin of corynebacterium diphtheriae. it is generally used in mixtures with tetanus toxoid and pertussis vaccine; dtp; or with tetanus toxoid alone dt for pediatric use and td which contains 5 to 10 fold less diphtheria toxoid for other use. diphtheria toxoid is used for the prevention of diphtheria; diphtheria antitoxin is for treatment.
  • FOWLPOX-. a poxvirus infection of poultry and other birds characterized by the formation of wart like nodules on the skin and diphtheritic necrotic masses cankers in the upper digestive and respiratory tracts.
  • DIPHTHERIA TETANUS PERTUSSIS VACCINE-. a vaccine consisting of diphtheria toxoid; tetanus toxoid; and whole cell pertussis vaccine. the vaccine protects against diphtheria tetanus and whooping cough.
  • DIPHTHERIA TETANUS VACCINE-. a combined vaccine used to prevent infection with diphtheria and tetanus toxoid. this is used in place of dtp vaccine diphtheria tetanus pertussis vaccine when pertussis vaccine is contraindicated.
  • DIPHTHERIA TETANUS ACELLULAR PERTUSSIS VACCINES-. combined vaccines consisting of diphtheria toxoid; tetanus toxoid; and an acellular form of pertussis vaccine. at least five different purified antigens of b. pertussis have been used in various combinations in these vaccines.
  • HEPARIN BINDING EGF LIKE GROWTH FACTOR-. an egf family member that is expressed in a variety of hematopoietic endothelial vascular smooth muscle and epithelial cells. it is synthesized as a transmembrane protein which is cleaved by proteases to produce the secreted form of the protein which has specificity for the egf receptor and the erbb 4 receptor. the membrane bound form of the protein has been identified as the receptor which binds to and allows diphtheria toxin to enter cells.

Code Classification

  • Certain infectious and parasitic diseases (A00–B99)
    • Other bacterial diseases (A30-A49)
      • Diphtheria (A36)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Information for Patients


Diphtheria

Diphtheria is a serious bacterial infection. You can catch it from a person who has the infection and coughs or sneezes. You can also get infected by coming in contact with an object, such as a toy, that has bacteria on it.

Diphtheria usually affects the nose and throat. Symptoms include

  • Sore throat
  • Swollen glands in the neck
  • Fever
  • Weakness

Your doctor will diagnose it based on your signs and symptoms and a lab test. Getting treatment for diphtheria quickly is important. If your doctor suspects that you have it, you'll start treatment before the lab tests come back. Treatment is with antibiotics.

The diphtheria, pertussis, and tetanus vaccine can prevent diphtheria, but its protection does not last forever. Children need another dose, or booster, at about age 12. Then, as adults, they should get a booster every 10 years. Diphtheria is very rare in the United States because of the vaccine.

Centers for Disease Control and Prevention


[Learn More]